Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if FENC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
16 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 28 days ago
Red flags: 8
106 filers reported a long position in FENC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Rosalind Advisors, Inc. | $34.3M | 3.2M | +9.6% |
| AIGH Capital Management LLC | $26.7M | 2.5M | +25.5% |
| Solas Capital Management, LLC | $20.3M | 1.9M | -23.9% |
| BlackRock, Inc. | $18.6M | 1.7M | +26.2% |
| AWM Investment Company, Inc. | $12.5M | 1.2M | +61.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | $9M | 839.3K | -6.4% |
| Prospect Capital Advisors, LLC | $5.4M | 497.8K | New |
| STATE STREET CORP | $4.6M | 426K | +18.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $4.3M | 402.6K | +8.3% |
| JANE STREET GROUP, LLC | $2.5M | 233.9K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.